Abiopharma

🔍 Brophy Michael Burkes (Executive)

Company: Natera, Inc. (NTRA)

Report Date: 2026-01-14

Detailed Transactions and Holdings:

• Acquired 59,596 shares of Common Stock (Direct)
  Date: 2026-01-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 123,722.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: On January 27, 2023, the Reporting Person was granted a performance-based Restricted Stock Unit (RSU) award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 14, 2026, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 59,596 shares of Common Stock.